Cargando…
Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis
Pancreatic cancer has a five-year overall survival rate <5%, a situation that has not improved since for 40 years. Diabetes mellitus including type 2 diabetes mellitus (T2D) is a suspected risk factor for the development of pancreatic cancer and nearly 45% of the pancreatic cancer cases are likel...
Autores principales: | Tan, Jiaxin, You, Yu, Guo, Fei, Xu, Jianhua, Dai, Haisu, Bie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403376/ https://www.ncbi.nlm.nih.gov/pubmed/28454242 http://dx.doi.org/10.3892/ol.2017.5586 |
Ejemplares similares
-
MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells
por: You, Yu, et al.
Publicado: (2017) -
Preexisting Diabetes Elevates Risk of Local and Systemic Complications in Acute Pancreatitis: Systematic Review and Meta-analysis
por: Mikó, Alexandra, et al.
Publicado: (2018) -
Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review
por: Zhou, You, et al.
Publicado: (2022) -
PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells
por: Dai, Haisu, et al.
Publicado: (2019) -
ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis
por: Wang, Anbin, et al.
Publicado: (2019)